BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15743884)

  • 1. Local coordination verses systemic disregulation: complexities in leukocyte recruitment revealed by local and systemic activation of TLR4 in vivo.
    Kerfoot SM; Kubes P
    J Leukoc Biol; 2005 Jun; 77(6):862-7. PubMed ID: 15743884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4.
    Kishore SP; Bungum MK; Platt JL; Brunn GJ
    FEBS Lett; 2005 Jan; 579(3):699-704. PubMed ID: 15670831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock up-regulates expression of Toll-like receptor-2 and Toll-like receptor-4 in human monocytes via p38 kinase signal pathway.
    Zhou J; An H; Xu H; Liu S; Cao X
    Immunology; 2005 Apr; 114(4):522-30. PubMed ID: 15804289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?
    Elovitz MA; Mrinalini C
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1149-55. PubMed ID: 16157128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings.
    Michel O; LeVan TD; Stern D; Dentener M; Thorn J; Gnat D; Beijer ML; Cochaux P; Holt PG; Martinez FD; Rylander R
    J Allergy Clin Immunol; 2003 Nov; 112(5):923-9. PubMed ID: 14610481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells.
    Ojeda MO; van't Veer C; Fernández Ortega CB; Araña Rosainz Mde J; Buurman WA
    Inflamm Res; 2005 Feb; 54(2):74-81. PubMed ID: 15750714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial endotoxin (lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the toll-like receptor 4.
    Tichomirowa M; Theodoropoulou M; Lohrer P; Schaaf L; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
    J Neuroendocrinol; 2005 Mar; 17(3):152-60. PubMed ID: 15796767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation.
    Zhou H; Andonegui G; Wong CH; Kubes P
    J Immunol; 2009 Oct; 183(8):5244-50. PubMed ID: 19786543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
    Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
    Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes.
    Kokkinopoulos I; Jordan WJ; Ritter MA
    Mol Immunol; 2005 May; 42(8):957-68. PubMed ID: 15829287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-induced leukocyte-endothelial cell interactions: a role for CD14 versus toll-like receptor 4 within microvessels.
    Andonegui G; Goyert SM; Kubes P
    J Immunol; 2002 Aug; 169(4):2111-9. PubMed ID: 12165539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.
    Wang AP; Migita K; Ito M; Takii Y; Daikoku M; Yokoyama T; Komori A; Nakamura M; Yatsuhashi H; Ishibashi H
    J Autoimmun; 2005 Aug; 25(1):85-91. PubMed ID: 16006099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism.
    van der Graaf C; Kullberg BJ; Joosten L; Verver-Jansen T; Jacobs L; Van der Meer JW; Netea MG
    Cytokine; 2005 Jun; 30(5):264-8. PubMed ID: 15927851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling in B cells via Toll-like receptors.
    Peng SL
    Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation.
    Goralski KB; Abdulla D; Sinal CJ; Arsenault A; Renton KW
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G434-43. PubMed ID: 15878984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver.
    Uhrig A; Banafsche R; Kremer M; Hegenbarth S; Hamann A; Neurath M; Gerken G; Limmer A; Knolle PA
    J Leukoc Biol; 2005 May; 77(5):626-33. PubMed ID: 15860798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice.
    Nakamura M; Shimizu Y; Sato Y; Miyazaki Y; Satoh T; Mizuno M; Kato Y; Hosaka Y; Furusako S
    Eur J Pharmacol; 2007 Aug; 569(3):237-43. PubMed ID: 17588563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.